性别医学与药物洗脱冠状动脉支架 - Suppr

Suppr

超能文献

Gender medicine and drug eluting coronary stents.

作者信息

Kornowski Ran

出版信息

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850.

DOI:10.1002/ccd.22850

PMID:21104730

Abstract

摘要

相似文献

Gender medicine and drug eluting coronary stents.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850.

Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.

JACC Cardiovasc Interv. 2009 Aug;2(8):776-8. doi: 10.1016/j.jcin.2009.06.010.

A critical appraisal of the Janus carbostent.

Catheter Cardiovasc Interv. 2009 Feb 1;73(2):249-50. doi: 10.1002/ccd.21958.

Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):804-13. doi: 10.1002/ccd.22624. Epub 2010 Sep 2.

Stent strut fracture: seeing is believing.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. doi: 10.1002/ccd.21569.

A generation 2.5 drug-eluting stent?

JACC Cardiovasc Interv. 2009 Oct;2(10):986-8. doi: 10.1016/j.jcin.2009.06.017.

Treating the left main bifurcation lesion: the "three stent solution".

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):42-3. doi: 10.1002/ccd.21906.

Late restenosis following sirolimus-eluting stent implantation.

JACC Cardiovasc Interv. 2011 Jan;4(1):123-8. doi: 10.1016/j.jcin.2010.09.013.

Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.

Circ Cardiovasc Interv. 2009 Jun;2(3):188-95. doi: 10.1161/CIRCINTERVENTIONS.108.823443. Epub 2009 May 8.

The process of bringing new drug-eluting stents to market will they see the light of day?

JACC Cardiovasc Interv. 2008 Oct;1(5):533-4. doi: 10.1016/j.jcin.2008.08.001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Gender medicine and drug eluting coronary stents.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850.

Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.

JACC Cardiovasc Interv. 2009 Aug;2(8):776-8. doi: 10.1016/j.jcin.2009.06.010.

A critical appraisal of the Janus carbostent.

Catheter Cardiovasc Interv. 2009 Feb 1;73(2):249-50. doi: 10.1002/ccd.21958.

Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):804-13. doi: 10.1002/ccd.22624. Epub 2010 Sep 2.

Stent strut fracture: seeing is believing.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. doi: 10.1002/ccd.21569.

A generation 2.5 drug-eluting stent?

JACC Cardiovasc Interv. 2009 Oct;2(10):986-8. doi: 10.1016/j.jcin.2009.06.017.

Treating the left main bifurcation lesion: the "three stent solution".

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):42-3. doi: 10.1002/ccd.21906.

Late restenosis following sirolimus-eluting stent implantation.

JACC Cardiovasc Interv. 2011 Jan;4(1):123-8. doi: 10.1016/j.jcin.2010.09.013.

Circ Cardiovasc Interv. 2009 Jun;2(3):188-95. doi: 10.1161/CIRCINTERVENTIONS.108.823443. Epub 2009 May 8.

The process of bringing new drug-eluting stents to market will they see the light of day?

JACC Cardiovasc Interv. 2008 Oct;1(5):533-4. doi: 10.1016/j.jcin.2008.08.001.